Arcadia Biosciences (RKDA) news
Recent news
Arcadia Biosciences - selling stockholders may offer up to 11.92 mln shares of common stock for resale - SEC filing
AInvest Wire · Jun 26, 2026Arcadia Biosciences (RKDA) announces $4 million private placement priced at-the-market under Nasdaq rules
Arcadia Biosciences, Inc. (Nasdaq: RKDA), a producer and marketer of plant-based health and wellness products, has announced a $4 million private placement priced at-the-market under Nasdaq rules. The offering includes the sale of common stock and associated preferred investment options, with the…
AInvest Wire · Jun 12, 2026Arcadia $750m TLB for repricing; call June 8
Arcadia has announced a $750 million term loan B (TLB) facility aimed at repricing existing debt, with a call date set for June 8, 2026. The move reflects ongoing efforts by the city to optimize its debt structure amid evolving market conditions. The transaction is expected to provide Arcadia with…
AInvest Wire · Jun 8, 2026Arcadia Biosciences Q4 EPS $(2.10) Beats $(2.58) Estimate, Sales $1.17M Miss $1.75M Estimate
AInvest Wire · Mar 28, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.